Compile Data Set for Download or QSAR
Report error Found 418 Enz. Inhib. hit(s) with all data for entry = 11962
TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665345(US20240116910, Compound 29)
Affinity DataIC50: 3nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665511(US20240116910, Compound 195)
Affinity DataIC50: 3nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665344(US20240116910, Compound 28)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665385(US20240116910, Compound 69)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665389(US20240116910, Compound 73)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665423(US20240116910, Compound 107)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665428(US20240116910, Compound 112)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665449(US20240116910, Compound 133)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665450(US20240116910, Compound 134)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665472(US20240116910, Compound 156)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665495(US20240116910, Compound 179)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665496(US20240116910, Compound 180)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665559(US20240116910, Compound 243)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665339(US20240116910, Compound 23)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665341(US20240116910, Compound 25)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665357(US20240116910, Compound 41)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665364(US20240116910, Compound 48)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665369(US20240116910, Compound 53 | (2S)-2-({5-[(1S)-1-[(...)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665375(US20240116910, Compound 59)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665403(US20240116910, Compound 87)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665410(US20240116910, Compound 94)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665424(US20240116910, Compound 108)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665451(US20240116910, Compound 135)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665452(US20240116910, Compound 136)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665455(US20240116910, Compound 139)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665457(US20240116910, Compound 141)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665459(US20240116910, Compound 143)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665469(US20240116910, Compound 153)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665479(US20240116910, Compound 163)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665494(US20240116910, Compound 178)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665544(US20240116910, Compound 228)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665560(US20240116910, Compound 244)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665592(US20240116910, Compound 276)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665317(US20240116910, Compound 1 | 5-[1-(3-chloroanilino)...)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665322(US20240116910, Compound 6)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665327(US20240116910, Compound 11)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D(Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665330(US20240116910, Compound 14)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D(Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665333(US20240116910, Compound 17)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665343(US20240116910, Compound 27)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665346(US20240116910, Compound 30)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665353(US20240116910, Compound 37)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665368(US20240116910, Compound 52)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665376(US20240116910, Compound 60)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665378(US20240116910, Compound 62)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665384(US20240116910, Compound 68)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665386(US20240116910, Compound 70)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665391(US20240116910, Compound 75)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665393(US20240116910, Compound 77)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665394(US20240116910, Compound 78)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665404(US20240116910, Compound 88)
Affinity DataIC50: 6nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 418 total ) | Next | Last >>
Jump to: